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eventually initiates their dislocation into the cytosol for proteolysis by 26S proteasomes. This process is termed ER
associatedproteindegradation (ERAD). The spatial separationof ERbasedquality control and cytosolicproteolysis
poses the need for amachinery that promotes the extraction of substrates from the ER. Due to the heterogeneous
nature of the client proteins this transport system displays several unique features. Selective recognition of ERAD
substrates does not involve transferable transport signals in the primary sequence and thus must follow other
principles than established for proteins designated for the import into organelles. Moreover, an ER dislcocation
systemmust be capable to ship polypeptides, whichmay be at least partly folded and are inmost cases covalently
modiﬁed with bulky and hydrophilic glycans, through a membrane without disrupting the integrity of the ER. In
this review we present current ideas on the highly dynamic and ﬂexible nature of the dislocation apparatus and
speculate on themechanism that removes aberrant polypeptides from the ER in the course of ERAD. This article is
part of a Special Issue entitled Protein translocation across or insertion into membranes.translocation across or insertion into membranes.
olecular Medicine, Robert-Rössle-Str. 10, 13125 Berlin, G
h), tsommer@mdc-berlin.de (T. Sommer).
l rights reserved.© 2010 Elsevier B.V. All rights reserved.Contents1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 926
2. General considerations for an ERAD protein-export machinery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 927
3. Targeting of ERAD substrates: a tight link of protein folding, quality control and substrate selection . . . . . . . . . . . . . . . . . . . . 928
3.1. Glycan structures serve as ERAD signals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 928
3.2. Targeting of integral membrane proteins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 928
4. Substrate receptors involved in dislocation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 928
5. A protein-conducting channel for ERAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 929
5.1. The role of the Sec61 translocon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 929
5.2. Derlin-1, a component of the ERAD ligases involved in substrate transport . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 930
5.3. ERAD ligases may contribute to pore formation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 930
6. ER proteins may be exported by lipid droplets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 930
7. ATP-hydrolysis provides the energy for substrate re-translocation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 931
7.1. Involvement of Hsp70-type chaperones . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 931
7.2. Polyubiquitylation is required for protein export . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 931
7.3. Involvement of proteasomes in dislocation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 931
7.4. A cytosolic AAA-ATPase involved in substrate export . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 932
8. A model for the dynamic organization of the dislocation apparatus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 933
9. Concluding remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 933
Acknowledgement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 933
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 934ermany. Tel.: +49 30 9406 3753, +49 30 9406 3305; fax: +49 30
926 K. Bagola et al. / Biochimica et Biophysica Acta 1808 (2011) 925–9361. Introduction
Secretory proteins enter the endplasmic reticulum (ER) in an
unfolded state through the narrow Sec61 translocation channel [1].
Folding of these polypeptides starts immediately once the nascent
chains emerges in the ER. Some proteins adopt their native structure
spontaneously within seconds whereas maturation of others requires
the action of folding enzymes and may take up to several hours. To
facilitate structural biogenesis of newly imported polypeptides the ER
is cramped with protein-folding and protein-modifying enzymes.
Hsp70- and Hsp90-type chaperones engage hydrophobic patches on
unfolded clients, protect them from aggregation and assist in their
structural biogenesis. Oligosaccharyltransferase covalently attaches
complex glycan structures to most secretory proteins, which assist
local folding and increase their hydrophilicity. These moieties
undergo rigid processing and serve as dynamic labels for the
recruitment of a varying set of chaperone-like lectins like calnexin
and calreticulin [2]. Maturation of many secretory proteins also
depends on protein disulﬁde isomerases, which oxidize pairs of
cysteine residues for the formation of thioester bonds. Productive
folding often requires multiple reshufﬂing of the disulﬁde bonds by
isomerization or by breaking and reformation in repeated cycles of
reduction and oxidation.
Still, folding of polypeptides is error-prone and often produces
terminally aberrant conformers. Moreover, defects within the client
protein or the folding machinery, environmental stress or the
unbalanced synthesis of partner proteins can increase the load of
the ER with improperly folded polypeptides. To avoid leakage of such
species into neighboring compartments the ER harbors a protein
quality control system (PQC) that retards immature proteins until
they have adopted their native structure [3,4]. At the same time this
system accomplishes the removal of the products of futile folding
attempts and thereby prevents congestion of the ER with aberrant
molecules. Thus, the ER-PQC has to evaluate the maturation of non-
native proteins and eventually distinguish productively folding
molecules from polypeptides that ultimately will fail to reach theirFig. 1. A simpliﬁedmodel for ERAD. Proteins enter the ER in an unfolded state through the na
are encountered by folding factors like chaperones, glycosylating enzymes or protein oxidore
the ER. Proteins that have attained their native conformation are released from the folding
system sorts out terminally misfolded species (4) and targets them to substrate-receptors
dislocated into the cytosol by an unknown mechanism (6) where they are polyubiquitylated
promotes the transport to proteasomes (9) where the polypeptides are ﬁnally degraded (1native conformation. Since both species expose similar properties of
unfolding, e.g. hydrophobic patches at their surfaces, additional
signals must exist that allow a reliable discrimination.
More than 15 years ago several observations implied that
proteolysis of malfolded secretory proteins is mediated by the
cytosolic ubiquitin-proteasome system. This process was later termed
ER associated protein degradation (ERAD) [5–7]. Central for ERAD are
ubiquitin ligases, which form large heteromeric protein complexes in
the ER membrane and provide a functional link between the selection
of appropriate substrates in the ER and cytosolic protein degradation.
These components are conserved in all eukaryotic organisms, which
underscores the importance of this process for cellular homeostasis. A
simpliﬁed view on the steps resulting in the degradation of misfolded
proteins from the ER is depicted in Fig. 1. In yeast, two distinct
ubiquitin ligase complexes promote degradation of proteins with
different topologies. The Hrd1 ligase predominantly mediates degra-
dation of soluble, ER luminal substrates and integral membrane
proteins harboring folding defects in either their ER luminal or their
transmembrane regions. Integral membrane proteins with lesions in
their cytosolic domains are primarily targeted by Doa10. Mammals
contain a much larger set of ERAD ligases but the reason for this is
unclear (see Table 1).
Although intricate at a ﬁrst glance, the spatial separation of protein
maturation within the ER from the degradation of aberrant species in
the cytosol likely contributes to the speciﬁcity of the process by the
protection of folding intermediates from premature digestion.
However, due to this organization proteasomal decomposition of
ERAD substrates has to be preceded by their extraction from the ER.
Currently, only vague ideas exist on themechanism by which proteins
are removed from the ER in the course of ERAD.Most prominently two
major questions await answer: What is the nature of the protein-
conducting channel that allows passage of ERAD substrates through
the ER membrane, and what provides the driving force that
determines the directionality of this transport process. In adaptation
to the heterogenous nature of the substrates cells have developed
multiple and concurrent pathways for ERAD. In this review we wantrrow Sec61 translocon (1). During or immediately after their import, these polypeptides
ductases (2). This facilitates structural maturation and retains unfolded polypeptides in
machinery and are transported to their ﬁnal destinations (3). A protein quality control
of membrane-bound ubiquitin ligases (5). Subsequently, the misfolded proteins are
(7). A complex containing the AAA-ATPase p97/Cdc48 binds to the substrates (8) and
0).
Table 1
A list of established ERAD factors in yeast and mammals. Most of the mammalian ubiquitin ligases are poorly described and possibly contribute to the degradation of only a limited
number of ERAD substrates. In these cases we also lack knowledge on the interacting co-factors that probably determine the speciﬁcity of the ligases towards substrates. Please note
that components of the ER-PQC and cytosolic factors that are generally involved in ubiquitin-proteasome dependent protein turnover are not included in this list (with the exception
of the p97/Cdc48 complex).
[122–125],[126], [15,127], [128], [16], [129], [16], [130,131], [29,30,32,132], [133], [134,135], [136,137], [138,139], [32,65,67,140–142], [56,57,59,143], [106–108], [98].
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protein dislocation apparatus that removes defective proteins from
the ER for proteasomal degradation.
2. General considerations for an ERAD protein-export machinery
ERAD substrates have to be extracted from the ER to become
accessible to the ubiquitin-proteasome system. This transport process
comprises several unique features. Proteins destined for the import
into organelles often contain deﬁned signal sequences that direct
them to the corresponding import machinery [1,8]. ERAD substrates,
by contrast, are a heterogeneous mixture of aberrant proteins
exhibiting distinct topologies that may expose a variety of different
properties. In principal, every secretory protein can be converted to an
ERAD substrate by mutations within its coding sequence, environ-
mental stress, exposure to deleterious agents, imbalanced synthesis of
binding partners or defects in the folding machinery. Thus, selection
of ERAD substrates supposedly involves recognition of global features.
Importantly, it is probably the combination of several such properties
that triggers export and degradation by the ERAD machinery.
Exposure of hydrophobic patches alone is in many cases not sufﬁcient
to elicit ERAD probably because such patterns are usually found on
aberrant proteins and folding intermediates alike. Current models
postulate that additional signals, like the association of certain lectins,
allow discrimination between productively folding and terminally
aberrant species. These tokens allow binding to receptors, which
should reside in close proximity to the dislocation site in the ER
membrane and initiate the displacement of the substrate.
Dislocation of single spanning membrane proteins, which only
expose small moieties into the ER lumen, may not rely on a dedicated
export apparatus but could be accomplished directly by cytosolic
factors. By contrast, export of polytopic membrane proteins, which
contain multiple hydrophobic transmembrane segments and oftenform complex structures that are stabilized by intramolecular
interactions, most likely depends on a specialized apparatus. These
requirements differ again from the demands raised for the dislocation
of ER luminal proteins and membrane proteins containing large ER
luminal domains. In the case of glycoproteins highly hydrophilic and
bulky glycan moieties have to traverse the ER membrane, because
removal of the oligosaccharides is exclusively accomplished by
peptide N-glycanase, which is conﬁned to the cytosol [9]. Some of
the substrates may even have adopted a partial folding, which is not
completely dismantled prior to export. Therefore, it is generally
believed that the dislocation of ER proteins occurs via proteinacous
channels of unknown composition. Such conduits must be capable to
accommodate polypeptides that bear complex glycan moieties and
that have obtained an at least partly folded state. Hence the size of this
pore should be signiﬁcantly larger than observed for the known
protein import channels in the mitochondria or the ER. At the same
time an ERAD pore must be efﬁciently gated to prevent unspeciﬁc
leakage of small solutes and to preserve the oxidizing environment of
the ER. We would also expect the transport apparatus to be in
proximity to the site of substrate selection. Most notably the ubiquitin
ligase complexes should be closely associated because the export of
ER proteins was shown to depend on their polyubiquitylation.
As shown for the import of proteins into organelles, themovement
of polypeptides through a membrane depends on a driving force that
deﬁnes the directionality of the process [1,8]. In these cases, unfolded
polypeptides are pushed or pulled through the transport-channels by
a mechanical force exerted from energy-consuming protein com-
plexes. A similar requirement is expected for the dislocation of ER-
proteins. In principle such transport motors could be localized on
either side of the membrane but they should be associated with the
export channel and have direct access to the ERAD substrate. Cytosolic
factors can only get hold on parts of client proteins that are exposed
into this compartment. Therefore, at least ER luminal proteins have to
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putative dislocation apparatus in the cytosol.
3. Targeting of ERAD substrates: a tight link of protein folding,
quality control and substrate selection
It is currently not knownwhich properties discriminate terminally
misfolded proteins from intermediates of the folding process or fully
matured species. The identiﬁcation of such faulty elements probably
involves the combination of structural rather than functional criteria.
Because unfolded polypeptides are retained in the ER by a PQC the
time a polypeptide spends in this compartment may serve to evaluate
its maturation status.
3.1. Glycan structures serve as ERAD signals
For glycoproteins a selection process has been elucidated, which is
based on the interplay of glycan-processing and the dynamic
recruitment of a varying set of lectin-binding proteins to substrates.
This system, termed the mannose-timer model, has recently been
extensively reviewed [2,7]. During their import, most secretory
proteins are covalently modiﬁed with complex glycan moieties,
which is necessary for their proper folding. Processing by glucosidase
I and II removes two terminal glucose residues from this structure and
triggers the recruitment of chaperone-like lectins like calnexin and
calreticulin to the polypeptide. Glucosidase II eventually cleaves the
last remaining glucose from the glycan, which reduces the afﬁnity for
calnexin/calreticulin and the polypeptide is released. Proteins that
have obtained their native conformation at this stagemay leave the ER
and get transported to their ﬁnal destinations. In mammals, UDP-
glucose:glycoprotein glucosyltransferase (UGT1) counteracts gluco-
sidase II by the reglucosylation of glycans on unfolded polypeptides
and thereby diverts client proteins to calnexin/calreticulin for
continuing folding attempts. UGT1 itself has an increased afﬁnity for
molten globular structures but binds much less efﬁcient to polypep-
tides with severe folding defects.
Removal of α(1,2)-bonded mannose-residues on the glycan
generates a code that is deciphered by the ERAD machinery: The
sequential action of ERmannosidase I (ERManI inmammals andMns1
in yeast) and EDEMs (Htm1 in yeast) exposes a terminal α(1,6)-
bonded mannose on the glycan, which is recognized by ERAD
receptors harboring a MRH-domain like OS-9 and XTP3-B (Yos9 in
yeast). At the same time the activity of these mannosidases prevents
re-glucosylation of the oligosaccharide by UGT1 and therefore
irreversibly excludes the polypeptide from the calnexin/calreticulin
folding cycle. Processing by ERManI is rather slow and may serve to
restrict the time expended for the folding attempts of a polypeptide.
EDEM1 associates with the protein oxido-reductase ERdj5 that
supposedly dissolves disulﬁde bonds on ERAD substrates prior to
their dislocation. This ﬁnding further strengthens the view that
EDEMs, and possibly Htm1 in yeast, play a crucial role in the selection
of ERAD substrates. However, the α(1,6)-bonded mannose token
generated by these enzymes cannot serve as the sole signal to initiate
ERAD because native glycoproteins residing in the ERmay also expose
such moieties but are not degraded.
Not all aberrant secretory proteins are targeted by ERAD. CPY* is
a mutant version of the yeast vacuolar carboxypeptidase Y that is
retained in the ER and degraded via the Hrd1 ligase complex. This
ERAD substrate is glycosylated at four distinct positions. Removal of
the most carboxyterminal glycosylation site abrogates recognition
and subsequent degradation by the ERAD machinery although the
protein is still malfolded and detained in the ER [10,11]. Mutations
of the other glycosylation sites does not affect turnover. This ﬁnding
indicates that not only the structure of glycanmoieties but also their
positioning within a polypeptide contributes to the selection of
ERAD substrates. Indeed, by the introduction of small deletions,which supposedly impair proper folding of the neighboring
peptides, non-ERAD glycans could be converted to ERAD targeting
signals [12].
Degradation of the type I transmembrane glycoproteins BACE476,
a misfolded version of the human-β-secretase BACE, and CD3-δ, an
orphaned subunit of the CD3 T-cell receptor, depends on EDEM1 but is
unaffected in cells downregulated for OS9 and XTP3-B. Removal of the
transmembrane segments from these ERAD substrates detaches them
from the membrane but still renders the proteins instable. Impor-
tantly, turnover of these glyco-polypeptides now completely depends
on OS9 and XTP3-B [13]. This observation implies that the activity of
EDEM1 targets membrane-bound and soluble glycoproteins via
different mechanisms: de-mannysolation of membrane-bound pro-
teins appears to trigger ERAD predominantly by preventing UGT1
mediated re-glucosylation and association with calnexin/calreticulin.
By contrast, processing of soluble glycoproteins requires binding of
the substrate receptors OS9 and XTP3-B to oligosaccharide structures
generated by EDEM1 and subsequent delivery to the ERAD ligases.
3.2. Targeting of integral membrane proteins
There is not much known, how integral membrane proteins are
targeted for ERAD. Supposedly, defects in the folding and assembly of
the transmembrane regions also affect the biogenesis of soluble
domains, which may then be recognized by the ER-PQC. In yeast
membrane proteins with lesions in their cytosolic parts are degraded
via the Doa10 ubiquitin ligase [14,15]. Mammalian Teb4/MARCHIV is
homologous to Doa10, but also other ubiquitin ligases, like cytosolic
CHIP and the membrane-bound RMA1/Rnf5, appear to contribute to
this process [16,17]. Substrate recruitment by the Doa10 ligase
eventually involves cytosolic Hsp70- and Hsp90-type chaperones,
however the detailed mechanisms have to be elucidated here.
Moreover, Teb4/Doa10 contains multiple transmembrane segments
of unknown function. Since the sequence of some of these domains is
highly conserved they may also partake in substrate selection.
BAP31, an integral membrane protein that localizes to the ER and
post ER compartments in mammalian cells, participates in
the biogenesis of numerous membrane-bound secretory proteins
[18–23]. Yeast contains three homologous proteins termed Yet1, 2
and 3 [24]. BAP31 associates with membrane proteins and is required
for vesicular trafﬁcking and cell surface expression of several clients.
Contrary to this, BAP31 also provokes ER retention of some other
polypeptides. It was therefore speculated that BAP31 serves as a
component of the ER-PQC for membrane proteins that monitors the
structural integrity of targets and routes them either to further
transport in the secretory pathway or for degradation by ERAD.
Actually, BAP31 was recently shown to be associated with compo-
nents of the translocon as well as the ERAD apparatus [25]. Moreover,
downregulation of BAP31 retards the degradation of CFTRΔF508, a
mutant version of the cystic-ﬁbrosis conductance regulator that is
retained in the ER and subjected to rapid ERAD. Yet the details of
BAP31 function in ERAD are still obscure.
4. Substrate receptors involved in dislocation
Aberrant proteins must be selectively recognized by speciﬁc
substrate-recruiting factors, which are located at the ER-membrane
and should initiate their degradation. SEL1L (Hrd3 in yeast), a protein
that is closely associated with the Hrd1 ubiquitin ligase, has been
implicated to serve such purpose [26]. This protein comprises a large
soluble region exposed into the ER lumen, which contains several
TPR-type domains. TPR motives were shown to mediate protein-
protein interactions but their function in SEL1L/Hrd3 remains to be
elucidated. Yeast Hrd3 regulates the speciﬁcity of the Hrd1 ligase. In
its absence, Hrd1 becomes instable and is degraded by ERAD [27,28].
Strong overexpression of Hrd1 but not of a catalytically inactive
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Under these conditions Hrd1 mediates the degradation of ER proteins
that are not targeted by ERAD in wild type cells. Hrd3 binds unfolded
polypeptides in the ER lumen irrespective whether they constitute
substrates of the Hrd1 ERAD-ligase [30]. These observations collec-
tively suggest that Hrd3 ascertains speciﬁcity of substrate selection by
scanning bound proteins for structural defects.
SEL1L/Hrd3 interacts with the bona ﬁde substrate receptors XTP3-
B and OS9/Yos9 and recruits them to the ERAD ligases [26,31–33].
Yeast Yos9 was shown to bind glycans via its MRH-domain with a
strong preference for molecules exposing terminal α(1,6)-bonded
mannoses [34]. Therefore, this protein supposedly detects aberrant
glycoproteins processed byMns1 and Htm1 and routes them to ERAD.
Indeed, deletion of Yos9 delays the turnover of glycosylated ERAD
substrates, whereas degradation of non-glycosylated proteins is not
affected [35–38]. However, Yos9 and its mammalian homologues bind
malfolded proteins even when their MRH-domains are mutated and
eventually also interact with non-glycosylated ERAD substrates. Thus,
selection by these lectins probably relies on the combination of
certain features within the glycan as well as the peptide part of a
substrate. In some cases EDEM1 may also directly deliver glycopro-
teins to the ERAD ligases [39].
5. A protein-conducting channel for ERAD
5.1. The role of the Sec61 translocon
Before ERAD substrates can be encountered by the proteasome,
they have to be extracted from the ER and get translocated into the
cytosol. This process involves most likely a proteinaceous conduit in
the ER membrane. An attractive candidate for such a dislocation
channel is the Sec61 translocon, which mediates the import of
proteins into the ER. Central component of this complex is Sec61α
(Sec61 in yeast), an integral protein of the ERmembrane that forms an
aqueous pore. Due to extensive biochemical studies the function of
Sec61 in protein transport is well documented [1]. Because no other
ER protein with the obvious ability to convey proteins across a
membrane was identiﬁed so far it is reasonable to speculate that the
Sec61 channel may promote both the import and the dislocation of
secretory proteins from the ER. Indeed, intense research over the
previous years provided some evidence for such a function.
In mammals the cytomegalovirus (CMV) co–opts ERAD and
eliminates major histocompatibilty complex class I molecules (MHC I)
from infected cells to increase the infection rate. Two viral proteins, US2
andUS11 individually bind toMHC I and trigger their polyubiquitylation
and degradation. Interestingly, upon inhibition of the proteasome an
interaction of Sec61αwithMHC I in US2-expressing cells was observed
[40]. Similarly, yeast Sec61 could be chemically crosslinked with a
misfolded version of pre-pro α-factor but not with a fully folded form
[41]. Very recently, Schäfer et al. demonstrated that Sec61 binds a
soluble and short-lived ER protein that was fully glycosylated and thus
has apparently been completely imported into the ER [42]. Noteworthy,
components of the HRD-ligase were not required to establish this
association implying a putative function of Sec61 upstream of this
enzyme complex. Moreover, Sec61 can be co-puriﬁed with Hrd3, the
substrate receptor of the HRD-ligase.
Expression of Sec61-2, a mutant variant of the translocon, in yeast
causes the accumulation of a fully glycosylated ERAD substrate
whereas the amount of the cytosolic precursor is not increased [43].
These data imply that Sec61-2 speciﬁcally affects the export of this
protein from the ER while remaining functional for import. Another
mutant, Sec61-3, also abolishes the degradation of soluble and
membrane bound ER proteins although translocation of these
molecules into the ER is not disturbed [44]. Still, impaired ERAD
observed in Sec61 mutant strains could also result from a mild delay
in the import of substrates or some limiting ERAD factors.Furthermore, Sec61 was implicated to serve as a transporter for
the export of cholera toxin from the ER of mammalian cells [45]. This
AB-type toxin enters the cell by endocytosis and reaches the ER via
vesicular transport, where the catalytic A-subunit is separated from
the regulatory B-polypeptide by the protein oxidoreductase PDI. The
A-subunit is subsequently activated to the A1 form (CTA1) that is
transported across the ER membrane into the cytosol where it
constitutively activates a chloride channel. In an in vitro reconstituted
system CTA1 was imported into isolated microsomes and could be re-
exported in an ATP dependent manner. CTA1 speciﬁcally co-puriﬁed
with Sec61α in these experiments. Moreover, incubation of CTA1-
loaded microsomes with saturating amounts of an import substrate
blocked the release of the toxin. However, in this study CTA1 was ﬁrst
imported into the microsomes via Sec61, which complicates the
interpretation of the results.
Convincing data argue against a general involvement of the Sec61
translocon in protein retrotranslocation. It is currently unclear
whether aberrant proteins completely dissociate from the translocon
after their import into the ER. Structural maturation of newly
imported polypeptides, such as glycosylation, is accomplished co-
translocationally during their import. At this early stage of protein
biogenesis irreversible structural aberrations may have already been
manifested within the polypeptide and attracted the ERAD machin-
ery. Additionally, misfolding of secretory proteins may eventually
cause prolonged association with the translocation complex. There-
fore, binding of ERAD substrates to Sec61 may result from delayed
import rather than an active retargeting to this channel.
In mammalian cells a chimeric protein of MHC I and green
ﬂourescent protein (GFP) that is exposed into the ER lumen is
exported from the ER and degraded by the proteasome in the presence
of the CMV proteins US2 or US11 [46]. Retention of GFP ﬂuorescence
throughout the export process implies that a complete unfolding of
the substrate is not required for efﬁcient dislocation. However, this
experimental setup does not exclude partial unfolding during
transport followed by fast and spontaneous refolding in the cytosol.
Intriguingly, dihydrofolatreductase (DHFR) exposed to the ER lumen
by its fusion to MHC I can be efﬁciently degraded by ERAD, even when
the globular structure of DHFRwas arrested by the binding of the folate
analogue trimetrexate [47]. Thus, folding of DHFR does not affect its
extraction from the ER while under similar conditions its import into
the ER is blocked [48]. This suggests different mechanistic principles
and/or the implication of distinct factors for either transport process.
The crystal structure of the bacterial SecYEG translocon implies
that also the highly homologous Sec61 channel adopts an hourglass
shape in the ERmembranewith two funnels facing the cytosol and the
ER lumen, respectively [49]. Both funnels are connected by a central
hydrophilic passage with a maximal diameter of 20 Å that can
accommodate only unfolded or loosely structured polypeptides [1].
The ER-luminal side of this pore is ﬁlled by a short helix, termed the
plug, which supposedly serves as a gatekeeper to maintain the closed
state of the channel [50]. Current models suggest that the Sec61
conduit is opened by displacement of the plug once the signal
sequence of import substrates is inserted from the cytosolic side.
Conversely, insertion of proteins from the ER luminal side should
arrest the plug within the pore and thereby jam the channel for
protein transport. These ﬁndings conﬂict with a putative role of the
translocon in the shipment of partly folded and glycosylated proteins
from the ER into the cytosol.
Dislocation and degradation of at least some ER proteins occurs
independently of the Sec61 translocon. Yeast Ubc6 constitutes a tail-
anchored protein, which is integrated into the ER membrane in a
Sec61 independent manner [51]. Ubc6 is naturally short-lived and
constitutively degraded in a ubiquitin-proteasome dependent man-
ner via the Doa10 ligase [15]. Mutations affecting the function of
Sec61 do not delay Ubc6 turnover, even under condition where Sec61
mediated protein import is substantially impaired [52].
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transport
Other ER transmembrane proteins have been implicated to serve
as transport channels for ERAD (Fig. 2). Yeast Der1 is a small protein
that associates with the Hrd1 ERAD ligase. Deletion of der1 abolishes
the turnover of proteins exposing large ER luminal domains, whereas
degradation of the majority of membrane-bound polypeptides is not
affected [53,54]. Der1 is integrated into the ER by four transmembrane
segments and exposes a small carboxyterminal region into the cytosol
[55]. Mammals express at least three homologous proteins termed
Derlin-1, -2, -3. Whereas Derlin-1 and -2/-3 show a sequence
similarity of about 30%, Derlin-2 and Derlin-3 seem to be more
evolutionaly related being ~70% identical [56–58]. Like Der1 the
Derlins have also been found in association with ERAD ligases but are
involved in the turnover of soluble as well as integral membrane
proteins. Derlin-1, -2, -3 seem to be required for distinct degradation
pathways. US11 mediated MHC I degradation exclusively involves
Derlin-1 whereas Derlin-2 and -3 are speciﬁcally required for the
turnover of the null Hong Kong (NHK) mutant of α1-antitrypsin
[57,59]. Interestingly, Derlin-1 was shown to bind substrates before
and after their extraction from the ER. Immunoprecipitation experi-
ments from lysates of cells treated with proteasomal inhibitor reveal a
preferred association of Derlin-1 with glycosylated MHC I, which is
still integrated in the ER membrane. Noteworthy, deglycosylated and
thus cytosolic forms of MHC I can also be puriﬁed with Derlin-1 [57].
Although it was not determined whether Derlin-1 directly interacted
withMHC I under the described conditions these observations suggest
that Derlin-1 is in close proximity to ERAD substrates during the
entire export process.
Such an assumption is supported by in vitro studies on the carriage
of pre-pro α-factor and cholera toxin through microsomal mem-
branes. Isolated microsomes were loaded with ﬂuorescently labelled
pre-pro α-factor and subsequently incubated with reticulocyte lysate
and ATP [60]. Under these conditions a considerable amount of
ﬂuorescence is released from themicrosomes indicative for the export
of the pre-pro α-factor. Antibodies against Derlin-1 abolished export
in this system whereas Sec61α speciﬁc antibodies had no effect.
Furthermore, pre-pro α-factor could be chemically cross-linked toFig. 2. Candidates for a protein-conducting channel for ERAD. The export of aberrant
proteins from the ER most likely depends on a proteinaceous pore that promotes
traversal of hydrophilic polypeptides through the ER membrane. Early observations
favored an involvement of the Sec61 translocon in this process, although the properties
of this channel deduced from its crystal structure are in conﬂict with a general function
in ERAD. Instead, components of the ERAD apparatus, like Der1/Derlin-1, -2, -3 or the
transmembrane segments found in the ERAD ubiquitin ligases may form highly
dynamic oligomeric assemblies that comprise transient pores for the export of proteins.
Although highly attractive, this model is only speculative and awaits proof. In some
cases, specialized factors like viral proteins may bind to particular target proteins in the
ER and thereby promote their extraction from the membrane.Derlin-1 but not to Sec61α. In a similar experimental setup, cholera
toxin can be liberated from microsomes in semi-permeabilized cells
[61]. Expression of a dominant negative Derlin-1 variant substantially
delays toxin release. These ﬁndings have been taken as an indication
that the Derlin proteins partake in the formation of an export channel.
In line with this, Derlin-1 as well as yeast Der1 was shown to form
oligomeric assemblies in the ER membrane [62,63].
5.3. ERAD ligases may contribute to pore formation
Most ERAD ligases containmultiple transmembrane segments that
anchor them in the ER-membrane. Although they comprise a large
portion of the enzymes, no speciﬁc function has been assigned to
these parts. Of note, the transmembrane segments contain polar and
hydrophilic amino acids at conserved positions. Changing some of
these residues of yeast Hrd1 to a hydrophobic one speciﬁcally affects
the activity of the ligase towards membrane-bound proteins [64].
Binding of substrates to the ligase is not impaired in these mutants.
Intriguingly, some of these Hrd1 variants are defective for the
turnover of a speciﬁc substrate while being functional for the
processing of others. Studies using gel ﬁltration and sucrose gradient
centrifugation revealed an apparent molecular weight of the yeast
Hrd1 ERAD ligase complex of about 800 kDa [32,65]. In line with this,
Hrd1 was shown to form oligomers via its interaction with the
membrane protein Usa1 [65]. This oligomeric assembly seems to be
required for the degradation of membrane proteins but dispensable
for the turnover of luminal substrates. A dimeric organization has also
been proposed for mammalian Hrd1 and gp78, respectively, but the
functional consequences on protein dislocation have not been
investigated [66,67]. Still, these observations imply that the trans-
membrane segments of Hrd1 and possibly also of other ERAD ligases
are important elements involved in the selection and/or the export of
membrane-bound proteins.
Extraction of certain ER proteins may rely on a highly specialized
membrane-bound machinery. Expression of the HIV protein Vpu
abolishes surface expression of the CD4 receptor. Vpu binds to newly
synthesized CD4 in the ER and recruits the cytosolic ubiquitin ligase
complex SCF-βTRCP, which polyubiquitylates CD4 and thereby
initiates its dislocation from the ER and proteasomal degradation
[68]. This process relies on p97 function but does not seem to require
any of the previously discussed channel candidates [69]. Notably, the
membrane protein Vpu has been shown to oligomerize and form ion-
conducting channels, which may also partake in the export of CD4
from the ER [70].
6. ER proteins may be exported by lipid droplets
It is currently under debate whether a channel composed solely by
proteins can adopt the very large pore size required for the export of
ERAD substrates. Alternatively, removal of misfolded proteins from
the ER could be accomplished by the formation of lipid droplets [71].
Lipid droplets are found in nearly all organisms and were primarily
identiﬁed as lipid storage devices. They contain a core of neutral lipids,
which are surrounded by a monolayer of phospholipids [72]. Lipid
droplets bud and form an independent organelle upon the synthesis
of neutral lipids between the leaﬂets of the ERmembrane. Due to their
high content of proteins like enzymes for cholesterol synthesis, Rab
proteins and also chaperones it is assumed that lipid droplets are
involved in diverse metabolic and trafﬁcking pathways [73]. Recent
studies have shown that lipid droplets partake in the degradation of
the secretory protein ApoB [73,74]. During its turnover ubiquitylated
ApoB accumulates around lipid droplets and is thereby exposed to the
proteasomal and autophagic degradation system, respectively. Addi-
tionally, ER stress increases the formation of lipid droplets, which
encourages the clearance of accumulating misfolded proteins from
the ER [75]. It remains to be determined, whether clearance of
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degradation pathway or rather represents a specialized stress induced
mechanism in certain cell types.
7. ATP-hydrolysis provides the energy for substrate re-translocation
7.1. Involvement of Hsp70-type chaperones
As determined in a reconstituted in vitro system, export of proteins
from the ER relies on ATP hydrolysis [76]. This energy requirement
may in part contribute to the unfolding of client proteins, which could
precede their dislocation. Indeed, the ER luminal Hsp70-type
chaperone BiP/Kar2p and its Hsp40-type cofactors Jem1 and Scj1
have been found in association with ERAD ligases where they
supposedly prevent the aggregation of substrates [77]. It is still
unclear, however, whether complete unfolding of all substrate
molecules is a prerequisite for their transport into the cytosol
[46,47]. Hsp70-type chaperones have also been shown to contribute
to the selection and recruitment of substrates to the ERAD ligases. In
analogy to organellar import systems, conformational changes by
these proteins that are coupled to ATP hydrolysis may also directly
contribute to the driving force for protein dislocation. Intriguingly,
though, there is no indication for such a function of Hsp70s in ERAD
[78].
7.2. Polyubiquitylation is required for protein export
Attachment of ubiquitin, a 76 residue polypeptide that is highly
conserved in all eukaryotes, modulates protein function in numerous
cellular processes like cell cycle progression, DNA repair, endocytosis
and cell signalling [79,80]. By formation of an isopeptide bond this
modiﬁer is covalently linked via its carboxyterminus usually to lysine
or an aminoterminal methionine residue within target proteins.
Ubiquitin can also be conjugated to one of the seven lysines within
other ubiquitin molecules that are already attached to substrates.
Depending on the lysine used the resulting polyubiquitin chains
display individual structural properties and fulﬁll different cellular
functions [81]. Most prominently, lysine 48-linked (K48) polyubiqui-
tin chains target proteins for proteasomal degradation.
Protein ubiquitylation depends on the sequential action of an
enzymatic cascade. In a ﬁrst step a cysteine residue within the
catalytic active center of the ubiquitin-activating enzyme forms a
thioester with the carboxyterminal glycine of ubiquitin. By a
transesteriﬁcation reaction ubiqiuitin is then delivered to a cysteine
in the catalytic active centre of highly conserved ubiquitin-conjugat-
ing enzymes. The ﬁnal attachment to client proteins relies in most
cases on the activity of ubiquitin ligases, which also account for the
speciﬁcity of this process. Thus, a particular combination of ubiquitin-
conjugating enzymes and ubiquitin ligases usually targets a deﬁned
set of client proteins in a spatially and temporally tightly regulated
manner. For ERAD, several pathways have evolved that are each
deﬁned by a specialized ubiquitin ligase. Yeast ERAD comprises two
different ligase complexes for the degradation of secretory proteins
with distinct topologies [32,54,82]. Mammals contain multiple ERAD
pathways with partly overlapping functions [6]. Interestingly, the
activity of certain ligases may be regulated by proteolysis but the
reason for this is unknown [83–85].
Polyubiquitylation of ERAD substrates does not only label these
polypeptides for proteasomal degradation but is also crucial for their
dislocation from the ER. Expression of mutant ubiquitin that cannot
form K48-linked chains blocks the export of ribophorin A, unassem-
bled TCRα and of MHC I in the presence of viral US11 [86–88]. Yeast
cells lacking the ubiquitin-conjugating enzymes Ubc1 and Ubc7
accumulate the ERAD substrate CPY* in a proteinase K resistant
form at the ER [89]. The function of polyubiquitylation in the export
step is not completely clariﬁed. Most likely the attachment of multipleubiquitin moieties serves as a handle for the association of ubiquitin-
binding factors that facilitate the extraction of the polypeptides from
the ER [90].
7.3. Involvement of proteasomes in dislocation
The 26S proteasome is a multi-enzyme protease that is built up by
two large sub-complexes [91,92]. A 20S core particle (CP) consists of
four heteroheptameric rings that are organized in a barrel shaped
sructure. The inner pair of the rings is assembled by the β-subunits,
three of which comprise peptidase activity, whereas the outer rings
solely contain structural components termed the α-subunits. Inside
this assembly resides a narrow cavity, which holds the proteolytically
active domains of the protease. Since the cavity can only be accessed
via narrow openings at either end of the barrel the peptidases are
sealed from the environment. These entry sites are each gated by a
19S regulatory complex (RC) that binds to the CP. The RC is composed
of a basal ring containing six AAA-ATPases and an associated structure
termed the lid. Selectivity of proteasomal degradation is assured by
substrate-recruiting factors within the lid, which preferentially bind
K48-linked polyubiquitylated proteins [81]. Subsequently, ubiquitin is
removed from these clients by deubiquitylating enzymes associated
with the lid. Proteolytic processing of substrates depends on their
unfolding by the AAA-ATPases of the RC-base, which also funnel the
polypeptides into the cavity of the 20S core.
Perturbation of the proteasomal activity by the treatment with
chemical drugs or the use of speciﬁc loss-of-function mutations
generally results in the accumulation of polyubiquitylated ERAD
substrates. These species are found in the cytosol or at the cytosolic
side of the ER membrane demonstrating that they were exported
from the ER. It is therefore assumed that the dislocation of most ERAD
substrates occurs independently of proteasomal activity. Still there
may be exceptions of the rule. The degradation of some membrane-
bound proteins seems to be coupled to their extraction from the ER.
Deg1-Sec62-ProtA is an artiﬁcial ERAD reporter that was constructed
by the fusion of a short amino acid stretch conferring fast turnover to
the yeast Mat-α factor with transmembrane segments derived from
the ER protein Sec62 [93]. The resulting polypeptide is integrated into
the ER membrane of yeast cells but rapidly degraded in a ubiquitin-
proteasome dependent manner. Conditional mutants that cause a
partial inhibition of the proteasome resulted in the accumulation of
degradation intermediates, which contained the transmembrane
segments of the substrate but lacked the soluble cytosolic domain.
Proteasomal inhibition also leads to the accumulation of the
transmembrane part of Ubc6, a naturally short-lived tail anchored
ER protein [52]. These data led to the speculation that proteasomes
are directly involved in the extraction of some proteins from the ER.
The partial obstruction of proteasomal activity may primarily impair
export and decomposition of the transmembrane regions of the
substrate whereas proteolysis of the cytosolic parts is affected to a
much lesser extent. Such a scenario is schematically displayed in
Fig. 3B and C. Still, efﬁcient turnover of at least Ubc6 depends on
another cytosolic AAA-ATPase termed the Cdc48/Npl4/Ufd1 complex
(see Section 7.4).
In vitro studies revealed a direct interaction of the Sec61 translocon
with the 19S regulatory particle base in the ATP-bound conformation
[94]. A mutant variant of Sec61α that displays defects in the
degradation of ERAD substrates shows reduced afﬁnity for the 19S
base in this assay [95]. Interestingly, proteasomes compete with
ribosomes for the interaction with the translocon, although either
complex seems to bind to a different site at Sec61α. These results
indicate that Sec61-bound proteasomes can directly extract proteins
from the ER. Support for such a scenario comes from in vitro studies on
the dislocation of yeast pre-pro α-factor. This substrate can be
exported from isolated microsomes upon the addition of puriﬁed RC
in an ATP dependent manner [96]. Subsequent apposition of 20S core
Fig. 3. Models on the extraction of ER proteins by the p97/Cdc48 complex and proteasomes. A) Polyubiquitylated proteins bind to p97/Cdc48 and are extracted from the ER upon
conformational transitions within this AAA-ATPase induced by ATP hydrolysis. Subsequently, the substrates are delivered to the proteasomes where they are degraded. B) In some
cases proteasomes may process membrane-bound polypeptides after their polyubiquitylation and also directly promote their extraction from the ER presumably by the activity of
the AAA-ATPases within the 19 S regulatory particle. C) Membrane-bound proteins may also be encountered by proteasomes that remove loosely folded, cytosolically exposed
regions. Extraction of the transmembrane segments may rely on the activity of p97/Cdc48, which then delivers these parts to proteasomes. D) Alternatively, dislocation of the
substrates may be accomplished by a so far unknown machinery. The predominant function of p97/Cdc48 in this process may be the mobilization of already exported polypeptides
from the cytosolic surface of the ER and their transport to proteasomes.
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α-factor is peculiar because polyubiquitylation appears to be
dispensable for its degradation in vivo.
7.4. A cytosolic AAA-ATPase involved in substrate export
In the cytosol the ERAD ligases team up with a multimeric enzyme
complex containing the AAA-ATPase p97/VCP (Cdc48 in yeast). p97/
Cdc48 forms homohexameric assemblies that are involved in many
cellular processes like homeotypic membrane fusion, cell cycle
progression, transcription factor processing and the degradation of
proteins by the ubiquitin-proteasome system [97,98]. Adaptation to
these different functions is most likely mediated by a large number of
interacting factors, which bind to p97/Cdc48 in an exclusive manner
and modulate its activities towards speciﬁc client proteins. For its
function in proteasomal protein degradation p97 associates with the
ubiquitin-binding proteins Ufd1 and Npl4, the ubiquitin chain-
elongation factor Ufd2, several deubiquitylating enzymes and other,
less well characterized proteins. Each monomer of p97 contains two
ATPase domains (D1 and D2) that catalyze ATP binding and
hydrolysis. The so-called N-domain of p97 directly binds ubiquitin
with a preference for multiubiquitin chains [99–101]. Structuralanalysis indicates a substantial re-arrangement within p97 upon
nucleotide binding and ATP hydrolysis [102]. These transformations
are thought to be conferred to bound substrates thereby loosening the
structure of the client molecules [103].
The majority of p97/Cdc48 localizes to the cytosol and the nucleus
[104,105]. Still, a signiﬁcant amount of this protein is found at the ER
and in association with the ERAD ligases. In yeast, the integral
membrane protein Ubx2 recruits Cdc48 via its UBX domain to the
Hrd1 and Doa10 ubiquitin ligases [106,107]. Remarkably, the
association of Cdc48 to the yeast ERAD ligases also depends on their
catalytic activity and may thus rely on the availability of substrates
[30,106]. Mammals contain a functional homologue of Ubx2 termed
erasin, which seems to be required for degradation of at least some
ERAD substrates [108,109]. The gp78 ERAD ligase directly interacts
with p97 by means of a discrete binding site at its very carboxy-
terminus [110].
In cells defective for p97/Cdc48 function degradation of most
ERAD substrates is impaired. Similarly, ERAD is abrogated in cells
lacking functional Ufd1 or Npl4. Under these conditions ERAD
substrates appear to have been at least partly dislocated into the
cytosol as indicated by their polyubiquitylation and susceptibility to
proteinase treatment but stay associated with the ER membrane
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tylated form inside the ER under comparable conditions [112,113].
Thus, the p97/Cdc48 complex may serve varying purposes in the
degradation of individual proteins: On the one hand it facilitates the
export of at least some ERAD substrates from the ER, possibly by
generating the driving force for their dislocation (Fig. 3A). The
polyubiquitylation of substrates most likely provides handles for the
association of the p97/Cdc48 complex here [90]. On the other hand,
this complex may also promote the mobilization of already dislocated
substrates from the ERAD ligases. Support for such a function arises
from the analysis of the Cdc48 dependent activation of the yeast
transcription factor Spt23 [100]. In its inactive form Spt23 forms a
homodimer that is integrated into the ER membrane. Limited
proteolytic processing by the proteasome removes the transmem-
brane segment of one subunit, thereby generating a 90 kDa protein
that is still bound to the ER by its tight association with the full length
partner. The Cdc48/Npl4/Ufd1 complex separates the heterodimer
thereby liberating the cleaved polypeptide from the membrane and
triggering Spt23 dependent transcription. Analogously, the Cdc48
complex may dissolve tight protein-protein interactions of ERAD
substrates and promote their release from the membrane [114], (see
Fig. 3D).
Finally, the activity of p97/Cdc48 is thought to prevent the
aggregation of ERAD substrates in the cytosol and to transport them
to the proteasome. In yeast, the U-box containing protein Ufd2
associates with p97/Cdc48 and extends the size of polyubiquitin
chains on client proteins [115]. Cells lacking Ufd2 exhibit a defect in
proteasomal degradation, possibly because the transport of substrates
from the Cdc48 complex to the proteasome is disturbed. The activity
of Ufd2 is counteracted by the deubiquitylating enzyme Otu1, which
binds to Cdc48 and restricts the size of polyubiquitin chains on
substrates [116]. This may adapt the chain length for the binding of
downstream acting ubiquitin binding factors. A direct requirement of
Otu1 for ERAD has not been shown, though. In mammalian cells the
deubiquitylating enzyme YOD1 binds to the p97 complex [117].
Overexpression of catalytically inactive YOD1 blocks the degradation
of the canonical ERAD substrates RI322, TCRα and α1-antitrypsin.
Strikingly, glycosylated as well as deglycosylated forms of RI322
accumulate under these conditions, indicating that protein dislocation
from the ER was at least partly compromised. The functional
implications of protein deubiquitylation in ERAD remain unclear at
this point.
8. Amodel for thedynamicorganizationof thedislocationapparatus
The vast diversity of ERAD substrates and their individual
structural and topological properties necessitates a varying array of
factors for their recognition, ubiquitylation and transport to the
proteasomes. It is conceivable to speculate that also the dislocation of
such molecules from the ER requires the dynamic assembly of
multiple components that adapts these machineries for the proces-
sing of a broad range of clients. Mammals contain numerous ERAD
ligases, which might reﬂect an adaptation for the processing of
peculiar substrates. As it has been implicated from the work on the
yeast Hrd1 ligase the transmembrane segments of these enzymesmay
contribute to the dislocation of client proteins. We may assume that
an oligomerization of these domains forms a protein-conducting
channel for the transport of substrates. The addition of ancillary
proteins like the Derlins or Der1 in yeast could extend the channel's
properties to handle substrates with particular features like folded ER
luminal domains. Alternatively, the Derlins and Der1 may form pores
on their own that are tightly associated with and controlled by the
ERAD ligases. Gating of such conduits is most likely accomplished by
substrate receptors like yeast Hrd3 or mammalian SEL1L, which
expose large domains into the ER lumen. In addition, these channels
may be regulated by the reversible assembly of membrane-boundERAD components that will dissociate upon completion of transport.
Thus, the dimension of the conduits could be dynamically adjusted to
meet the size of the cargo and allow passage of partly folded and
glycosylated polypeptides. Such a model matches with the observa-
tion that substrate dislocation is highly dependent on polyubiquityla-
tion because it unites these processes in a single entity. Moreover, this
organization of the dislocation apparatus places substrate selection in
the ER lumen and the activity of the cytosolic p97/Cdc48 complex in
close spatial proximity, which correlates to their tight functional
connection. Yet, this model is only speculative at the moment and
needs to be substantiated by experimental work.
Recent work implies that the import of proteins into peroxisomes
involves a dynamically organized importomer. In isolatedmicrosomes
the peroxisomal import receptor Pex5 and its membrane-docking
factor Pex14 can form variable pores with a diameter of up to 9 nm
[118]. Such channels ﬁt the notion that unlike other organelles
peroxisomes are capable to import even preassembled protein
complexes from the cytosol. Strikingly, also the recycling of the
import receptor Pex5 into the cytosol displaysmechanistic similarities
to ERAD. Pex5 binds import substrates in the cytosol and delivers
them to peroxisomes by insertion into the peroxisomal membrane.
After cargo release Pex5 is ubiquitylated by the ubiquitin ligases Pex2
and Pex12 [119]. This modiﬁcation is a prerequisite for the extraction
from the peroxisomal membrane by the AAA-ATPases Pex1 and Pex6
[120,121]. Polyubiquitylated Pex5 is degraded by proteasomes
whereas the monoubiquitylated form is recycled and may participate
in another round of protein import. Thus, the extraction of Pex5 from
peroxisomes parallels the current ideas on how the p97/Cdc48
complex dislocates ubiquitylated proteins from the ER membrane.
9. Concluding remarks
Intense research of the last two decades aimed to identify a general
ERAD apparatus for the degradation of aberrant secretory proteins.
Given the diversity of ERAD substrates it is of little surprise that these
efforts resulted in the identiﬁcation of multiple pathways that exhibit
discrete yet overlapping speciﬁcity towards client proteins. While
yeast gets along with two ubiquitin ligase complexes for the
processing of most ERAD substrates the number in mammalian cells
is considerably larger. The recruitment of ancillary factors further
expands the functional properties of the ligases althoughwe currently
lack a complete inventory of the components involved in these
individual ERAD routes. This variety may also result in mechanistic
differences for dislocation step that tribute to structural peculiarities
of some of the substrates. While the AAA-ATPase p97/Cdc48 appears
to procure the driving force in most of these pathways, the nature of a
dislocation channel remains obscure. A growing number of observa-
tions supports the idea that components of the ERAD ligases form
highly dynamic and adaptive pores capable of transporting glycosy-
lated and folded proteins through the ER membrane. Still, this
assumption awaits proof. Because some mammalian ERAD ligases
contain few or no transmembrane segments a putative dislocation
channel must be formed by additional factors in these pathways. In
the past studies on protein transport through biological membranes
strongly beneﬁted from potent in vitro systems that allowed the
characterization of deﬁned operational sequences. We are looking
forward to see the development of such a powerful tool for the ERAD
ﬁeld, which will boost our knowledge on the mechanisms of this
highly complex and dynamic process.
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